UCLA Researchers & Innovators
Industry & Investors
News & Events
About
Concierge
Search Results - mapk+signaling
1
Results
Sort By:
Published Date
Updated Date
Title
ID
Descending
Ascending
Methods and Compositions for Treating Melanoma (UCLA Case No. 2021-324)
The Graeber Laboratory at UCLA discovered a novel mechanism for treating melanoma using ferroptosis, a type of programmed cell death, that shows promise against therapy resistance. BACKGROUND: Melanoma is a highly aggressive skin cancer that spreads throughout the body and can be fatal if left untreated. Therapies for melanoma range from immunotherapy...
Published: 7/10/2024
|
Inventor(s):
Thomas Graeber
Keywords(s):
Cancer
,
ferroptosis
,
Immunotherapy
,
MAPK signaling
,
Melanoma
,
Oncology
,
Skin
,
tumor resistance
Category(s):
Therapeutics > Oncology
,
Therapeutics > Immunology And Immunotherapy